Stata Uygulamalı Panel Eşbütünleşme Testleri ve Model Tahminiyigitcanozmeral
Model seçimi için uygulanan testler sonucunda veriye sabit etkiler modelin uygun olduğu görülmüş, heteroskedasite, otokorelasyon ve birimler arası korelasyonun varlığı sınanmıştır. Birimler arası korelasyonun varlığından dolayı, serinin durağanlığı ikinci kuşak panel birim kök testleriyle incelenmiştir. Birimler arası korelasyonun varlığından dolayı, değişkenler arasında uzun dönemde bir denge ilişkisinin olup olmadığı ikinci kuşak panel eşbütünleşme testleriyle incelenmiştir. Homojenlik testi sonucunda bu testlerden heterojen olanlar kullanılmıştır. Model tahmin edilmiştir.
we need to update our knowledge regarding management of endometriosis.
Which is better: medications or surgery? let's see what can this talk tell us about
This document discusses fertility preservation options for cancer patients. It covers the impact of cancer and cancer treatments on female fertility. Current fertility preservation techniques include embryo cryopreservation, oocyte cryopreservation, and ovarian tissue cryopreservation. Embryo cryopreservation has high success rates but requires a male partner and time for stimulation. Oocyte cryopreservation overcomes some limitations but stimulation is still needed. Ovarian tissue cryopreservation allows immediate cancer treatment and is an option for young girls, but reimplantation risks remain experimental. Health care providers play a key role in discussing fertility preservation with patients.
Dr Sujoy Dasgupta was invited to deliver a lecture at the Conference of IMA (Indian Medical Association), held at July 2019 in Kolkata. This session was sponsored by Meyer Organic.
Pprom by dr alka mukherjee dr apurva mukherjee nagpur indiaalka mukherjee
Preterm premature rupture of the membranes (PPROM) is a pregnancy complication. In this condition, the sac (amniotic membrane) surrounding your baby breaks (ruptures) before week 37 of pregnancy. Once the sac breaks, you have an increased risk for infection. You also have a higher chance of having your baby born early.
In most cases of PPROM, the cause is not known.
These things may increase risk:
• Having a preterm birth in a previous pregnancy
• Having an infection in your reproductive system
• Vaginal bleeding during pregnancy
• Smoking during pregnancy
Symptoms can occur a bit differently in each pregnancy. They can include:
• A sudden gush of fluid from your vagina
• Leaking of fluid from your vagina
• A feeling of wetness in your vagina or underwear
Call your healthcare provider right away if you have these symptoms.
The symptoms of this health problem may be similar to symptoms of other conditions. See your healthcare provider for a diagnosis.
Diagnosis
• pH (acid-base) balance testing. The pH balance of amniotic fluid is different from vaginal fluid and urine. Your healthcare provider will put the fluid on a test strip to check the balance.
• Looking at a sample under a microscope. When amniotic fluid is dry, it has a fern-like pattern.
• ultrasound exam. This is done to check the amount of amniotic fluid around baby.
This document provides biographical information about Dr. Narendra Malhotra, an obstetrician and gynecologist from India. It lists his professional roles and accomplishments, which include being president of FOGSI, dean of ICMU, director of the Ian Donald School of Ultrasound, and editor of several medical books and journals. It also provides contact information for Malhotra Hospitals in Agra, India, where Dr. Malhotra practices and serves as a consultant for IVF procedures in several other cities.
Stata Uygulamalı Panel Eşbütünleşme Testleri ve Model Tahminiyigitcanozmeral
Model seçimi için uygulanan testler sonucunda veriye sabit etkiler modelin uygun olduğu görülmüş, heteroskedasite, otokorelasyon ve birimler arası korelasyonun varlığı sınanmıştır. Birimler arası korelasyonun varlığından dolayı, serinin durağanlığı ikinci kuşak panel birim kök testleriyle incelenmiştir. Birimler arası korelasyonun varlığından dolayı, değişkenler arasında uzun dönemde bir denge ilişkisinin olup olmadığı ikinci kuşak panel eşbütünleşme testleriyle incelenmiştir. Homojenlik testi sonucunda bu testlerden heterojen olanlar kullanılmıştır. Model tahmin edilmiştir.
we need to update our knowledge regarding management of endometriosis.
Which is better: medications or surgery? let's see what can this talk tell us about
This document discusses fertility preservation options for cancer patients. It covers the impact of cancer and cancer treatments on female fertility. Current fertility preservation techniques include embryo cryopreservation, oocyte cryopreservation, and ovarian tissue cryopreservation. Embryo cryopreservation has high success rates but requires a male partner and time for stimulation. Oocyte cryopreservation overcomes some limitations but stimulation is still needed. Ovarian tissue cryopreservation allows immediate cancer treatment and is an option for young girls, but reimplantation risks remain experimental. Health care providers play a key role in discussing fertility preservation with patients.
Dr Sujoy Dasgupta was invited to deliver a lecture at the Conference of IMA (Indian Medical Association), held at July 2019 in Kolkata. This session was sponsored by Meyer Organic.
Pprom by dr alka mukherjee dr apurva mukherjee nagpur indiaalka mukherjee
Preterm premature rupture of the membranes (PPROM) is a pregnancy complication. In this condition, the sac (amniotic membrane) surrounding your baby breaks (ruptures) before week 37 of pregnancy. Once the sac breaks, you have an increased risk for infection. You also have a higher chance of having your baby born early.
In most cases of PPROM, the cause is not known.
These things may increase risk:
• Having a preterm birth in a previous pregnancy
• Having an infection in your reproductive system
• Vaginal bleeding during pregnancy
• Smoking during pregnancy
Symptoms can occur a bit differently in each pregnancy. They can include:
• A sudden gush of fluid from your vagina
• Leaking of fluid from your vagina
• A feeling of wetness in your vagina or underwear
Call your healthcare provider right away if you have these symptoms.
The symptoms of this health problem may be similar to symptoms of other conditions. See your healthcare provider for a diagnosis.
Diagnosis
• pH (acid-base) balance testing. The pH balance of amniotic fluid is different from vaginal fluid and urine. Your healthcare provider will put the fluid on a test strip to check the balance.
• Looking at a sample under a microscope. When amniotic fluid is dry, it has a fern-like pattern.
• ultrasound exam. This is done to check the amount of amniotic fluid around baby.
This document provides biographical information about Dr. Narendra Malhotra, an obstetrician and gynecologist from India. It lists his professional roles and accomplishments, which include being president of FOGSI, dean of ICMU, director of the Ian Donald School of Ultrasound, and editor of several medical books and journals. It also provides contact information for Malhotra Hospitals in Agra, India, where Dr. Malhotra practices and serves as a consultant for IVF procedures in several other cities.
Invited Lecture delivered by Dr Sujoy Dasgupta in a CME, sponsored by Serum Institute of India Pvt Ltd in the Convocation Ceremony of Interns at Sagor Dutta Medical College
Platelet-rich plasma (PRP) is an autologous concentration of platelets that contains high levels of growth factors. It is used as a non-surgical treatment for various gynecological disorders by injecting PRP into the affected areas. PRP therapy involves drawing the patient's blood, centrifuging it to extract PRP, and injecting PRP to stimulate healing. It has shown benefits for sexual dysfunction, vaginal rejuvenation, reconstructive surgery, and breast reconstruction. PRP therapy is a simple, affordable, and low-risk procedure with few side effects and promising results for various gynecological applications.
Uterine Fibroids: Symptoms, Causes, Risk Factors & Treatment uterine fibroids aren't associated with an increased risk of uterine cancer and almost never develop into cancer
This document summarizes evidence on the use of progesterone to prevent preterm birth. It finds that progesterone reduces the risk of preterm birth before 37 weeks in women with a prior preterm delivery or short cervix. Progesterone may also reduce complications for infants born preterm to mothers receiving it. However, progesterone does not prevent early preterm birth in twin or triplet pregnancies. No long-term harms were seen in children exposed to progesterone prenatally.
Hysterectomy and endometrial ablation are treatments for heavy menstrual bleeding. The document reviews randomized controlled trials comparing the two procedures. It finds that hysterectomy is more effective at eliminating bleeding and has higher patient satisfaction rates up to 3 years post-surgery. However, endometrial ablation has shorter operating times and hospital stays. Complications are more common after hysterectomy, while repeat surgery is more likely after ablation. Overall, hysterectomy is more successful clinically while ablation offers shorter recovery.
Threatened Miscarriage Verdict is out on Hormonal Treatment Dr Jyoti AgarwalLifecare Centre
- Threatened miscarriage occurs in around 15% of clinically recognized pregnancies and can cause significant emotional and psychological stress for couples.
- Multiple meta-analyses and randomized controlled trials have found that oral administration of dydrogesterone is more effective at reducing the risk of miscarriage in cases of threatened miscarriage compared to vaginal progesterone or no treatment.
- Dydrogesterone has higher bioavailability when taken orally compared to micronized progesterone, requires a lower dose, and may have immunomodulatory properties that further reduce the risk of miscarriage.
Endometriosis is known to have a remarkably negative effect on the Quality of Life of the women. Surgery is considered when medical therapy is unsuccessful or in the setting of infertility. A high recurrence rate is reported in advanced stages of endometriosis. Thus, Complete excision and prevention of recurrence is particularly important.
This document discusses endometriosis and its relationship to infertility. It covers several key points:
1. Endometriosis has three main types - peritoneal, ovarian, and rectovaginal - which are different entities.
2. Endometriosis can result in infertility through mechanical effects, endocrine abnormalities, changes to peritoneal fluid, immune system issues, and defects in oocytes.
3. Diagnosis is confirmed through laparoscopy, and mild or minimal endometriosis associated with infertility can be treated through laparoscopic destruction, expectant management, or GnRH agonists. Surgery aims to decrease inflammation and toxicity.
4. For endometriomas,
Practical tips for monitoring of an iui cycleLifecare Centre
Ultrasound monitoring is the accepted method for monitoring infertility treatment cycles. It allows evaluation of follicle growth, endometrial development, and risk of ovarian hyperstimulation. Transvaginal ultrasound is recommended starting on day 6-8 of stimulation to measure follicle size and number. The leading follicle is typically 18-20mm at the time of hCG trigger. Endometrial thickness should be 7-14mm on the day of trigger. Doppler ultrasound can assess blood flow and predict ovarian response and uterine receptivity. With experienced use of ultrasound alone, additional hormonal monitoring is often unnecessary for cycle monitoring in infertility treatment.
This document discusses the role of progesterone in pregnancy and preventing preterm birth. It begins by outlining the problem of preterm birth globally, noting that 15 million babies are born preterm each year. It then discusses various trials investigating the use of progesterone supplementation to prevent preterm birth, including the large NICHD/MFMU trial which found that weekly injections of 17α-hydroxyprogesterone caproate reduced preterm birth rates. The document also notes vaginal progesterone trials have shown benefits but results are more mixed in high-order multiples and women with a short cervix may benefit most.
EVIDENCE BASED PRACTICAL TIPS FOR LUTEAL PHASE SUPPORT BY DR SHASHWAT JANIDR SHASHWAT JANI
This document provides evidence-based practical tips for luteal phase support. It summarizes various diagnostic criteria and treatments for luteal phase deficiency, including progesterone, hCG, and estrogen. While no single diagnostic test is definitive, vaginal progesterone is widely considered the most effective treatment due to its direct delivery to the endometrium. Progesterone supplementation is recommended over hCG to prevent ovarian hyperstimulation syndrome.
Recurrence of endometriosis is fairly common; some studies suggest the rate of recurrence to be as high as 40%. Most common cause of recurrence is incomplete resection in primary surgery and microscopic foci which escapes detection.
This document provides guidelines for thromboprophylaxis during pregnancy, labor, and after vaginal delivery. It outlines various risk factors for venous thromboembolism (VTE) including pre-existing conditions like previous DVT or thrombophilia, as well as transient risks from procedures, immobilization, or medical complications. It recommends individual assessment and management based on risk factor profile, including consideration of antenatal low molecular weight heparin for high risk groups like those with previous VTE or inherited thrombophilia. Postpartum prophylaxis for at least 6 weeks is also advised for many groups based on their VTE risk.
This document discusses endometriosis, including its pathogenesis, medical interventions, and changing treatment paradigms. It presents the case of a 25-year old woman with worsening pelvic pain and notes 80 ongoing clinical trials on the topic. New insights into biomarkers have led to newer medical treatments. While surgery was traditionally prioritized, endometriosis is now viewed primarily as a medical disease, with medical treatment preferred for superficial disease and surgery as back-up. The effectiveness of medical treatments like GnRH agonists and IUDs for pain and improved fertility with GnRH agonists prior to ART are summarized.
Selective progesterone receptor modulators (SPRMs)
Stimulates growth :
Up regulating epidermal growth factor (EGF)
Down regulating tumour necrosis factor-alpha expression
Inhibits growth :
Downregulating insulin-like growth factor-1 (IGF-1) expression
NO EFFECT ON ESTRADIOL LEVELS
Mifepristone : 5 or 10 mg per day for 1 year
Ulipristal acetate: 5-10mg/day for 13 weeks
Pro apoptotic and anti-proliferative effects on fibroid cells
Top Five Problems You Have with Ovulation Induction and How to Solve ThemSandro Esteves
The document discusses the top five problems with ovulation induction and how to solve them. It addresses whether protocols need to be individualized, how long clomiphene citrate should be used, the advantages of recombinant versus urinary gonadotropins, the advantages of recombinant versus urinary hCG, and whether LH supplementation is needed. It provides evidence-based recommendations including that protocols should be tailored based on biomarkers and individual factors, clomiphene citrate is usually first-line for up to 3 cycles, and recombinant gonadotropins yield higher pregnancy rates than clomiphene without increased risks.
The document discusses changing protocols for in vitro fertilization (IVF) from gonadotropin-releasing hormone (GnRH) agonists to GnRH antagonists. Some key points discussed include:
1) GnRH antagonists are associated with a lower risk of ovarian hyperstimulation syndrome (OHSS) compared to GnRH agonists.
2) While efficacy outcomes like live birth and pregnancy rates are similar between the two protocols, GnRH antagonists require fewer gonadotropin ampoules and have a shorter duration of stimulation.
3) Based on multiple randomized controlled trials and meta-analyses, it is justified to shift from GnRH agonists to GnRH antagonists for IVF
Invited Lecture delivered by Dr Sujoy Dasgupta in a CME, sponsored by Serum Institute of India Pvt Ltd in the Convocation Ceremony of Interns at Sagor Dutta Medical College
Platelet-rich plasma (PRP) is an autologous concentration of platelets that contains high levels of growth factors. It is used as a non-surgical treatment for various gynecological disorders by injecting PRP into the affected areas. PRP therapy involves drawing the patient's blood, centrifuging it to extract PRP, and injecting PRP to stimulate healing. It has shown benefits for sexual dysfunction, vaginal rejuvenation, reconstructive surgery, and breast reconstruction. PRP therapy is a simple, affordable, and low-risk procedure with few side effects and promising results for various gynecological applications.
Uterine Fibroids: Symptoms, Causes, Risk Factors & Treatment uterine fibroids aren't associated with an increased risk of uterine cancer and almost never develop into cancer
This document summarizes evidence on the use of progesterone to prevent preterm birth. It finds that progesterone reduces the risk of preterm birth before 37 weeks in women with a prior preterm delivery or short cervix. Progesterone may also reduce complications for infants born preterm to mothers receiving it. However, progesterone does not prevent early preterm birth in twin or triplet pregnancies. No long-term harms were seen in children exposed to progesterone prenatally.
Hysterectomy and endometrial ablation are treatments for heavy menstrual bleeding. The document reviews randomized controlled trials comparing the two procedures. It finds that hysterectomy is more effective at eliminating bleeding and has higher patient satisfaction rates up to 3 years post-surgery. However, endometrial ablation has shorter operating times and hospital stays. Complications are more common after hysterectomy, while repeat surgery is more likely after ablation. Overall, hysterectomy is more successful clinically while ablation offers shorter recovery.
Threatened Miscarriage Verdict is out on Hormonal Treatment Dr Jyoti AgarwalLifecare Centre
- Threatened miscarriage occurs in around 15% of clinically recognized pregnancies and can cause significant emotional and psychological stress for couples.
- Multiple meta-analyses and randomized controlled trials have found that oral administration of dydrogesterone is more effective at reducing the risk of miscarriage in cases of threatened miscarriage compared to vaginal progesterone or no treatment.
- Dydrogesterone has higher bioavailability when taken orally compared to micronized progesterone, requires a lower dose, and may have immunomodulatory properties that further reduce the risk of miscarriage.
Endometriosis is known to have a remarkably negative effect on the Quality of Life of the women. Surgery is considered when medical therapy is unsuccessful or in the setting of infertility. A high recurrence rate is reported in advanced stages of endometriosis. Thus, Complete excision and prevention of recurrence is particularly important.
This document discusses endometriosis and its relationship to infertility. It covers several key points:
1. Endometriosis has three main types - peritoneal, ovarian, and rectovaginal - which are different entities.
2. Endometriosis can result in infertility through mechanical effects, endocrine abnormalities, changes to peritoneal fluid, immune system issues, and defects in oocytes.
3. Diagnosis is confirmed through laparoscopy, and mild or minimal endometriosis associated with infertility can be treated through laparoscopic destruction, expectant management, or GnRH agonists. Surgery aims to decrease inflammation and toxicity.
4. For endometriomas,
Practical tips for monitoring of an iui cycleLifecare Centre
Ultrasound monitoring is the accepted method for monitoring infertility treatment cycles. It allows evaluation of follicle growth, endometrial development, and risk of ovarian hyperstimulation. Transvaginal ultrasound is recommended starting on day 6-8 of stimulation to measure follicle size and number. The leading follicle is typically 18-20mm at the time of hCG trigger. Endometrial thickness should be 7-14mm on the day of trigger. Doppler ultrasound can assess blood flow and predict ovarian response and uterine receptivity. With experienced use of ultrasound alone, additional hormonal monitoring is often unnecessary for cycle monitoring in infertility treatment.
This document discusses the role of progesterone in pregnancy and preventing preterm birth. It begins by outlining the problem of preterm birth globally, noting that 15 million babies are born preterm each year. It then discusses various trials investigating the use of progesterone supplementation to prevent preterm birth, including the large NICHD/MFMU trial which found that weekly injections of 17α-hydroxyprogesterone caproate reduced preterm birth rates. The document also notes vaginal progesterone trials have shown benefits but results are more mixed in high-order multiples and women with a short cervix may benefit most.
EVIDENCE BASED PRACTICAL TIPS FOR LUTEAL PHASE SUPPORT BY DR SHASHWAT JANIDR SHASHWAT JANI
This document provides evidence-based practical tips for luteal phase support. It summarizes various diagnostic criteria and treatments for luteal phase deficiency, including progesterone, hCG, and estrogen. While no single diagnostic test is definitive, vaginal progesterone is widely considered the most effective treatment due to its direct delivery to the endometrium. Progesterone supplementation is recommended over hCG to prevent ovarian hyperstimulation syndrome.
Recurrence of endometriosis is fairly common; some studies suggest the rate of recurrence to be as high as 40%. Most common cause of recurrence is incomplete resection in primary surgery and microscopic foci which escapes detection.
This document provides guidelines for thromboprophylaxis during pregnancy, labor, and after vaginal delivery. It outlines various risk factors for venous thromboembolism (VTE) including pre-existing conditions like previous DVT or thrombophilia, as well as transient risks from procedures, immobilization, or medical complications. It recommends individual assessment and management based on risk factor profile, including consideration of antenatal low molecular weight heparin for high risk groups like those with previous VTE or inherited thrombophilia. Postpartum prophylaxis for at least 6 weeks is also advised for many groups based on their VTE risk.
This document discusses endometriosis, including its pathogenesis, medical interventions, and changing treatment paradigms. It presents the case of a 25-year old woman with worsening pelvic pain and notes 80 ongoing clinical trials on the topic. New insights into biomarkers have led to newer medical treatments. While surgery was traditionally prioritized, endometriosis is now viewed primarily as a medical disease, with medical treatment preferred for superficial disease and surgery as back-up. The effectiveness of medical treatments like GnRH agonists and IUDs for pain and improved fertility with GnRH agonists prior to ART are summarized.
Selective progesterone receptor modulators (SPRMs)
Stimulates growth :
Up regulating epidermal growth factor (EGF)
Down regulating tumour necrosis factor-alpha expression
Inhibits growth :
Downregulating insulin-like growth factor-1 (IGF-1) expression
NO EFFECT ON ESTRADIOL LEVELS
Mifepristone : 5 or 10 mg per day for 1 year
Ulipristal acetate: 5-10mg/day for 13 weeks
Pro apoptotic and anti-proliferative effects on fibroid cells
Top Five Problems You Have with Ovulation Induction and How to Solve ThemSandro Esteves
The document discusses the top five problems with ovulation induction and how to solve them. It addresses whether protocols need to be individualized, how long clomiphene citrate should be used, the advantages of recombinant versus urinary gonadotropins, the advantages of recombinant versus urinary hCG, and whether LH supplementation is needed. It provides evidence-based recommendations including that protocols should be tailored based on biomarkers and individual factors, clomiphene citrate is usually first-line for up to 3 cycles, and recombinant gonadotropins yield higher pregnancy rates than clomiphene without increased risks.
The document discusses changing protocols for in vitro fertilization (IVF) from gonadotropin-releasing hormone (GnRH) agonists to GnRH antagonists. Some key points discussed include:
1) GnRH antagonists are associated with a lower risk of ovarian hyperstimulation syndrome (OHSS) compared to GnRH agonists.
2) While efficacy outcomes like live birth and pregnancy rates are similar between the two protocols, GnRH antagonists require fewer gonadotropin ampoules and have a shorter duration of stimulation.
3) Based on multiple randomized controlled trials and meta-analyses, it is justified to shift from GnRH agonists to GnRH antagonists for IVF
5. Misoprostol
• 1967 Robert ve ark. PG E serisi
– Hızlı metabolizma
– Yan etkiler
– Kısa raf ömrü
• Misoprostol (15-deoxy-16-hydroxy-16-
methyl PGE1)
– Oral yoldan etkili
– Uzun etki süresi
– Artmış güvenlik profili
– Uygun saklama koşulları
9. Yan Etkiler
• Diare
• Bulantı, kusma
• Ateş, titreme
• Ağızda hoş olmayan tad, uyuşma
• Hiperpreksi, delirium
• Abdominal kramp
• Uterus rüptürü
• Hematolojik, endokrin, biyokimyasal,
immünolojik, respiratuar, oftalmik,
trombosit ve kardiovasküler açıdan önemli
bir yan etkisi bulunmamaktadır
Teratojenite
• Embriyotoksik, fetotoksik ve
teratojenik bir etkisi
gösterilememiştir
• SSS ve ekstremite defektleri uterin
kontraksiyonlar ve bozulmuş kan
akımı?
Misoprostol- yan etkiler
11. Obstetrik Jinekoloji
Misoprostol-kullanım alanları
• Birinci - ikinci trimester
– İstemli düşük
– Erken fetal kayıp
– İnkomplet abort
• Üçüncü trimester
– İntrauterin fetal ölüm
– Postpartum kanama önlemi
– Postpartum kanama tedavi
• Jinekoloji
– Uterusu boşaltmadan önce
serviksin olgunlaştırılması
12. Off-label (Endikasyon dışı kullanım)
Misoprostol-yasal durum
• Doktorlar hangi öneriyi
dikkate almalı ?
– Üretici firma?
– DSÖ ?
– ACOG, RCOG… ?
– Cochrane Veritabanı ?
– Sağlık Bakanlığı
yönergeleri ?
1. Cytotec 200 µg 28 tb (misoprostol)
2. Arthrotec 50 mg 20 tb (diklofenak+ misoprostol)
13.
14. TÜRKİYE
NÜFUS PLANLAMASI HAKKINDAKİ KANUN
( 27. 05. 1983 ),18059 No’lu Resmi Gazete
• Madde 5
– Gebelik süresi 10 haftadan fazla ise, rahim ancak gebelik, annenin
hayatını tehdit ettiği veya edeceği veya doğacak çocuk ile, onu takip
edecek nesiller için ağır maluliyete neden olacağı hallerde Doğum ve
Kadın Hastalıkları uzmanı ile, ilgili daldan bir uzmanın objektif
bulgularına dayanan gerekçeli raporları ile tahliye edilir. ( Hafta sınırı
konulmamıştır. )
• Madde 6
– 5. maddede belirtilen müdahale için, gebe kadının izni, evli ise eşinin
de rızası gerekir.
Yasal durum
15. RAHİM TAHLİYESİ VE STERİLİZASYON HİZMETLERİNİN YÜRÜTÜLMESİ VE DENETLENMESİNE İLİŞKİN TÜZÜK
( 18. 12. 1983 ), 18255 No’lu Resmi Gazete
• Tahliyeye esas olan hastalıklar listesi.
• Tahliyeyi gerektiren raporun bir hafta içinde Sağlık
Müdürlüklerine gönderilmesi.
• Tahliyenin resmi veya özel yataklı tedavi kurumlarında
yapılabileceği koşulu.
Yasal durum
16. O ilaca yasak geldi!
09.07.2012
Düşük yaptıran ilaca yasak isyan ettirdi
Mide ülserini tedavide kullanılan ancak doğum
sonrası kanamaları durdurmada ve düşüğe
yardımcı olmada etkin olduğu için WHO’nun da
önerdiği Cytotec, 9 Temmuz’da Türkiye’de
yasaklandı. Bakanlık, “Amaç dışı kullanıldığı”
gerekçesiyle ilacın toplatılmasına karar verdi.
Yasağa en büyük tepki kadın doğum
uzmanlarından geldi.
19. • Plasenta Previa
• Fetosid
• Eski sezaryen
• Fetal anomali
Misoprostol & Özel durumlar
20. 4/41 (%9.7) uterus rüptürü
Kanuni Sultan Süleyman Perinatoloji Kliniği Deneyimi
21. 67 eski C/S ve 256 kontrol
Eski C/S grubunda rüptür yok , kontrol grubunda 1 adet
İndüksiyon-doğum intervali eski C/S grubunda daha uzun (p<0.001)
22. • Bir alt transvers C/S sonrası II. Trimester uterin rüptür oranı % 0.4 – 1.1
• Oksitosin eklenmesi, koryoamnionit
• > 26 hf , >1000µg <26hf
• Histerektomi yok, sadece birinde transfüzyon gereksinimi var
29. Eleştiriler
• Klinik yetenekleri törpüler
• Klinik yargı kaybolur
• Hekimlik “cookbook medicine” , hekim ise yaratıclığı
olmayan düşüncesiz bir otomata indirgenir
• Sayı ve yüzdelerle hekimlik
• Hani hastalık yoktu hasta vardı?
• Kanıta dayalı tıp, tecrübeli hekime karşı
– Yıllardır aynı yanlışları artan bir özgüvenle yapıyorsunuz !!!